[Angiogenesis and endothelial cells in blood neoplasms].
This paper contains a review of present opinions on neoplastic angiogenesis with a special attention to hematologic malignancies. Methods of the evaluation of angiogenesis were discussed. The participation of circulating endothelial cells and endothelial precursors in angiogenesis was shown. The most known antiangiogenic agents were presented.
Usnarska-Zubkiewicz
Lidia
L
Klinika Hematologii, Nowotworów Krwi i Transplantacji Szpiku Akademii Medycznej we Wrocławiu. sogood@poczta.onet.pl
Poreba
Małorzata
M
Kuliczkowski
Kazimierz
K
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D001853:Bone Marrow / Q000098:blood supply* / Q000473:pathology; D042783:Endothelial Cells / Q000187:drug effects / Q000473:pathology*; D004730:Endothelium, Vascular / Q000473:pathology / Q000503:physiopathology*; D006133:Growth Substances / Q000494:pharmacology / Q000502:physiology; D019337:Hematologic Neoplasms / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D009389:Neovascularization, Pathologic / Q000188:drug therapy / Q000503:physiopathology* / Q000517:prevention & control; D013792:Thalidomide / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D006133:Growth Substances; D013792:Thalidomide